切换至 "中华医学电子期刊资源库"

中华产科急救电子杂志 ›› 2015, Vol. 04 ›› Issue (01) : 5 -9. doi: 10.3877/cma.j.issn.2095-3259.2015.01.002

所属专题: 文献

专家论坛

妊娠合并白血病
张晓红1,(), 王大鹏1   
  1. 1. 100044 北京大学人民医院妇产科
  • 收稿日期:2014-09-11 出版日期:2015-02-18
  • 通信作者: 张晓红

Leukemia in pregnancy

Xiaohong Zhang1(), Dapeng Wang1   

  • Received:2014-09-11 Published:2015-02-18
  • Corresponding author: Xiaohong Zhang
引用本文:

张晓红, 王大鹏. 妊娠合并白血病[J]. 中华产科急救电子杂志, 2015, 04(01): 5-9.

Xiaohong Zhang, Dapeng Wang. Leukemia in pregnancy[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2015, 04(01): 5-9.

妊娠合并白血病是一个极其严重的产科合并症,母胎均面临高度风险。孕期应警惕患者血常规化验的异常结果,以及早诊断。孕期诊断的白血病患者需由产科、血液科综合管理,争取更好的母胎结局。本文就妊娠合并白血病的诊断、对母胎的影响、孕期的处理以及治疗过程中的伦理等问题进行讨论。

Leukemia in pregnancy is a severe obstetric complication, threatening the life of the mother and the baby. Abnormal indexes of blood test during prenatal care should be noticed to diagnose leukemia as soon as possible. The pregnant patients with leukemia should be treated under the obstetrician and hematologist to expect better maternal and fetal outcomes. In this article, the authors discussed the diagnosis, impact on mothers and fetus, obstetric management and the ethic issue of leukemia in pregnancy.

[1]
Hurley TJ. McKinnell JV, Irani MS. Hematologic malignancies in pregnancy[J]. Obstet Gynecol Clin North Am, 2005, 32(4):595-614.
[2]
Lavi N, Horowitz NA, Brenner B. An update on the management of hematologic malignancies in pregnancy[J]. Womens Health (Lond Engl), 2014, 10(3):255-266.
[3]
Ali R, Ozkalemkas F, Ozcelik T, et al. Maternal and fetal outcomes in pregnancy complicated with acute leukemia: a single institutional experience with 10 pregancies at 16 years[J]. Leuk Res, 2003, 27(5):381-385
[4]
王大鹏,梁梅英,张晓红,等. 妊娠合并白血病23例临床分析[J]. 中华围产医学杂志,2014, 17(2):93-98.
[5]
Döhner H, Estey EH, Amadori S, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet[J]. Blood, 2010, 115(3):453-474.
[6]
葛均波,徐永健. 内科学[M]. 8版. 北京:人民卫生出版社,2013:578.
[7]
Ali R, Ozkalemkas F, Ozkocaman V, et al. Successful pregnancy and delivery in a patient with chronic myelogenous leukemia(CML), and management of CML with leukapheresis during pregnancy:a case report and review of the literature[J]. Jpn J Clin Oneol, 2004, 34(4):215-217.
[8]
Saleh AJ, Alhejazi A, Ahmed SO, et al. Leukemia during pregnancy: long term follow up of 32 cases from a single institution[J]. Hematol Oncol Stem Cell Ther, 2014, 7(2):63-68.
[9]
Avivi I, Brenner B. Management of acute myeloid leukemia during pregnancy[J]. Future Oncol, 2014, 10(8):1407-1415.
[10]
Nomura RM, Igai AM, Faciroli NC, et al. Maternal and perinatal outcomes in pregnant women with leukemia[J]. Rev Bras Ginecol Obstet, 2011, 33(8):174-181.
[11]
Milojkovic D, Apperley JF. How I treat leukemia during pregnancy[J]. Blood, 2014, 123(7):974-984.
[12]
Chang A, Patel S. Treatment of acute myeloid leukemia during pregnancy[J]. Ann Pharmacother, 2015, 49(1):48-68.
[13]
Sanz MA, Jarque I, Martin G, et al. Acute promyelocytic leukemia. Therapy results and prognostic factors[J]. Cancer, 1988, 61(1):7-13.
[14]
Chelghoum Y, Vey N, Raffoux E, et al. Acute leukemia during pregnancy:a report on 37 patients and a review of the literature[J]. Cancer, 2005, 104(1):110-117.
[15]
Shapira T, Pereg D, Lishner M. How I treat acute and chronic leukemia in pregnancy[J]. Blood Rev, 2008, 22(5):247-259.
[16]
王大鹏,梁梅英,张晓红,等. 妊娠合并慢性粒细胞性白血病患者的临床处理特点及妊娠结局分析[J]. 中华妇产科杂志,2010, 45(10):735-739.
[17]
Yazdani Brojeni P, Matok I, Garcia Bournissen F, et al. A systematic review of the fetal safety of interferon alpha[J]. Reprod Toxicol, 2012, 33(3):265-268.
[18]
Webb MJ, Jafta D. Imatinib use in pregnancy[J]. Turk J Hematol, 2012, 29(4):405-408.
[19]
Yadav U, Solanki SL, Yadav R. Chronic myeloid leukemia with pregnancy: Successful management of pregnancy and delivery with hydroxyurea and imatinib continued till delivery[J]. J Cancer Res Ther, 2013, 9(3):484-486.
[20]
Mukhopadhyay A, Dasgupta S, Kanti Ray U, et al. Pregnancy outcome in chronic myeloid leukemia patients on imatinib therapy[J]. Ir J Med Sci, 2015, 184(1):183-188.
[21]
Azim HA Jr, Pavlidis N, Peccatori FA. Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: Hematological tumors[J]. Cancer Treat Rev, 2010, 36(2):110-121.
[1] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[2] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[3] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[4] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[5] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[6] 孙建娜, 孔令军, 任崇禧, 穆坤, 王晓蕊. 266例首诊Ⅳ期乳腺癌手术患者预后分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 502-505.
[7] 袁庆港, 刘理想, 张亮, 周世振, 高波, 丁超, 管文贤. 尿素-肌酐比值(UCR)可预测结直肠癌患者术后的长期预后[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 506-509.
[8] 黄福, 王黔, 金相任, 唐云川. VEGFR2、miR-27a-5p在胃癌组织中的表达与临床病理参数及预后的关系研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 558-561.
[9] 张瑜, 姜梦妮. 基于DWI信号值构建局部进展期胰腺癌放化疗生存获益预测模型[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 657-664.
[10] 伍细蓉, 徐立文, 陈亚琼. 基于LPR和FARI构建肝衰竭患者生存预后模型[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 675-681.
[11] 刘军, 丘文静, 孙方昊, 李松盈, 易述红, 傅斌生, 杨扬, 罗慧. 在体与离体劈离式肝移植在儿童肝移植中的应用比较[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 688-693.
[12] 李素娟, 王文玲, 董洪敏, 李小凯, 黄思成, 王刚. 多原发与单原发大肠腺癌的预后分析[J]. 中华消化病与影像杂志(电子版), 2024, 14(05): 407-412.
[13] 孙文恺, 沈青, 杭丽, 张迎春. 纤维蛋白原与清蛋白比值、中性粒细胞与白蛋白比值、C反应蛋白与溃疡性结肠炎病情评估和预后的关系[J]. 中华消化病与影像杂志(电子版), 2024, 14(05): 426-431.
[14] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
[15] 闫战涛, 王辉, 周梓迪, 史勇强, 陈铜兵. 胃淋巴上皮瘤样癌三级淋巴结构特征及其与预后的相关性[J]. 中华临床医师杂志(电子版), 2024, 18(05): 455-461.
阅读次数
全文


摘要